Bloomin' Brands (BLMN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Proxy filing submitted for shareholder review, including definitive additional materials.
No filing fee required for this submission, indicating routine annual meeting matters.
Voting matters and shareholder proposals
Proxy statement relates to voting on matters pursuant to Section 14(a) of the Securities Exchange Act.
Shareholder rights and capital structure
Filing includes information on securities classes and aggregate numbers relevant to voting rights.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Bloomin' Brands
- Q1 2026 delivered higher revenue, EPS, and margins, with guidance reaffirmed for the year.BLMN
Q1 20267 May 2026 - Turnaround strategy, board refresh, and pay-for-performance drive key proxy actions.BLMNProxy Filing3 Mar 2026
- Annual meeting to vote on directors, compensation, auditor, and key shareholder proposals.BLMNProxy Filing3 Mar 2026
- Q4 2025 saw higher revenues, improved traffic, and a turnaround focus, but lower margins.BLMNQ4 202525 Feb 2026
- Q2 adjusted EPS was $0.51; guidance cut as sales, margins, and traffic declined.BLMNQ2 20242 Feb 2026
- Q3 sales and earnings declined, with Brazil sale and lower guidance amid ongoing share buybacks.BLMNQ3 202415 Jan 2026
- Q4 earnings and sales fell as traffic lagged, Brazil was refranchised, and turnaround efforts began.BLMNQ4 202416 Dec 2025
- Board elections, executive pay, and a new incentive plan headline the 2025 proxy.BLMNProxy Filing1 Dec 2025
- Flat Q2 sales and margin pressure offset by Brazil divestiture and reaffirmed guidance.BLMNQ2 202523 Nov 2025